GLP-1 serves as both a peptide hormone and a growth factor, is released upon nutrient intake, and promotes insulin secretion stimulated by glucose levels
[8] [9] It is important to note that in the UK, tirzepatide for weight management is available under a separate brand name (Zepbound)
That said, it seems like a company with pretty much endless funds that is putting together a trial comparing dose differences, could create a trial with sufficient statistical power to accurately compare the dose differences
This means fewer opportunities to get key nutrients, not because of the medications themselves, but because overall intake drops, shares Vocca
World J Gastroenterol 2016, 22 (48), 1051210522.10.3748/wjg.v22.i48.10512 [DOI] [PMC free article] [PubMed] 149.Z
Expanding the NICE recommendation to a broader range of patients could further reduce the economic burden of obesity and its related conditions, whilst also reducing the NHS implementation period from 12 years to a much shorter timeframe, ensuring that the healthcare system and patients benefit from this technology
